Literature DB >> 11228853

Programming a fixed long atrioventricular delay is not effective in preventing ventricular pacing in patients with sick sinus syndrome.

J C Nielsen1, A K Pedersen, P T Mortensen, H R Andersen.   

Abstract

AIM: Most patients with sick sinus syndrome (SSS) and normal atrioventricular (AV) conduction receive dual chamber (DDDR) pacemakers. Programming a long AV delay has been proposed to avoid ventricular pacing. The present study aimed to evaluate ventricular stimulation in SSS patients with DDDR pacemakers with a long AV delay. METHODS AND
RESULTS: Thirty eight patients treated with DDDR pacemakers with a fixed long AV delay (300 ms) were studied. Data from the pacemaker event recorder were retrieved after 3 months and every year after implantation. Ten patients underwent 24 h Holter recording. Mean follow-up was 11.9 +/- 8.3 months. Median daily number of paced events in the ventricle was 2659 (25th-75th percentiles: 775-21 315) with a large inter-individual variation. The proportion of paced events in the ventricle correlated weakly with the baseline PQ interval (Spearman's rho 0.331, P = 0.043). In 12/38 patients the mean daily number of paced events in the ventricle exceeded 10,000. During 24 h Holter recording, pacemaker arrhythmias caused by repetitive retrograde atrioventricular conduction, known as VA (ventriculoatrial) conduction, occurred in five out of 10 patients.
CONCLUSION: DDDR pacing with a fixed long AV delay is inefficient in reducing ventricular pacing in one third of patients and is associated with a high risk of arrhythmias caused by repetitive retrograde AV conduction, and therefore cannot be recommended for general use in SSS patients.

Entities:  

Mesh:

Year:  1999        PMID: 11228853     DOI: 10.1053/eupc.1998.0026

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  8 in total

1.  Fifty years of cardiac pacing: the dark side of the moon?

Authors:  C C de Cock
Journal:  Neth Heart J       Date:  2008-10       Impact factor: 2.380

2.  The usefulness of minimal ventricular pacing and preventive AF algorithms in the treatment of PAF: the 'MinVPace' study.

Authors:  Rick A Veasey; Anita Arya; Nick Freemantle; John Silberbauer; Nikhil R Patel; Guy W Lloyd; A Neil Sulke
Journal:  J Interv Card Electrophysiol       Date:  2010-01-16       Impact factor: 1.900

3.  Cardiac Pacing for Bradycardia Support: Evidence-based Approach to Pacemaker Selection and Programming.

Authors:  Israel Galtes; Gervasio A. Lamas
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-10

4.  Reduction of right ventricular pacing in patients with sinus node dysfunction through programming a long atrioventricular delay along with the DDIR mode.

Authors:  Aischa Nitardy; Holger Langreck; Rainer Dietz; Martin Stockburger
Journal:  Clin Res Cardiol       Date:  2008-10-13       Impact factor: 5.460

5.  [Avoidance of ventricular pacing in patients with sinus node disease or intermittent AV block].

Authors:  U K H Wiegand
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2008-03

6.  Very Low Ventricular Pacing Rates Can Be Achieved Safely in a Heterogeneous Pacemaker Population and Provide Clinical Benefits: The CANadian Multi-Centre Randomised Study-Spontaneous AtrioVEntricular Conduction pReservation (CAN-SAVE R) Trial.

Authors:  Bernard Thibault; Anique Ducharme; Adrian Baranchuk; Marc Dubuc; Katia Dyrda; Peter G Guerra; Laurent Macle; Blandine Mondésert; Léna Rivard; Denis Roy; Mario Talajic; Jason Andrade; Rémi Nitzsché; Paul Khairy
Journal:  J Am Heart Assoc       Date:  2015-07-23       Impact factor: 5.501

Review 7.  The role of pacing in rhythm control and management of atrial fibrillation.

Authors:  John Silberbauer; Neil Sulke
Journal:  J Interv Card Electrophysiol       Date:  2007-05-02       Impact factor: 1.759

8.  Safety and efficacy of AAIR pacing in selected patients with sick sinus syndrome.

Authors:  Janek Senaratne; Thiloththama Thisaranie Herath; Diane Beaudette; Marleen Irwin; Sajad Gulamhusein; Manohara Piyasiri Senaratne
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.